BioCryst Pharmaceuticals BCRX Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- BioCryst Pharmaceuticals (BCRX) reported increase (decrease) in prepaid expense and other assets of -$3.53M in Q1 2026.
- How has BioCryst Pharmaceuticals's increase (decrease) in prepaid expense and other assets changed year-over-year?
- BioCryst Pharmaceuticals's increase (decrease) in prepaid expense and other assets decreased by 2775.8% year-over-year, from $132K to -$3.53M.
- What does increase (decrease) in prepaid expense and other assets mean?
- Represents the net change in payments made in advance for goods or services to be received in future periods. This metric helps track the timing of cash outflows relative to the recognition of related expenses.